{
    "fund_name": "Leverage Shares -3x Short Magnificent 7 ETP",
    "type": "ETP",
    "ucits": false,
    "replication_method": "synthetic",
    "leverage": true,
    "inverse": true,
    "derivatives": true,
    "swaps": true,
    "complex_factors": [
        "3x inverse leverage",
        "Synthetic replication",
        "Daily rebalancing with compounding effect",
        "High risk profile (Class 7/7)",
        "Short-term holding recommendation (1 day)",
        "Potential for significant losses",
        "Counterparty risk from collateral assets"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex due to multiple factors: (1) It uses synthetic replication with derivatives to achieve -3x inverse exposure to the Solactive Magnificent 7 Index, which introduces significant complexity. (2) The 3x leverage and inverse nature create a highly volatile and non-linear return profile that is difficult for retail investors to understand. (3) The product is designed for daily trading with a recommended holding period of just 1 day, making it unsuitable for long-term investors. (4) The risk profile is classified as the highest level (7/7), indicating very high risk. (5) The product involves counterparty risk through its collateralized structure. (6) The compounding effect means returns will diverge significantly from -3x the underlying index over longer holding periods, adding another layer of complexity. (7) The product is not UCITS-compliant, which is often a red flag for complexity. While the PRIIPs KID and factsheet might provide additional details, the core characteristics from the KIID are sufficient to classify this as a complex product under MiFID II.",
    "confidence": 95
}